When taking a GLP-1 medication, your bodys needs for nutrients and fluids are higher than average during the donation window
We are prepared for a full US launch in early January 2026, with manufacturing well underway in our North Carolina facilities." The FDA approval of Wegovy pill is based on the results from the OASIS 4 phase 3 clinical trial, which was a 64-week medical study that included 307 adults with obesity or overweight with one or more weight-related comorbidities, without diabetes
It works as a glucagon-like peptide-1 (GLP-1) analogue that helps to lower blood sugar levels and control appetite
Since Wegovy isnt listed on the national formulary, it will require a non-formulary request, and if the VA approves health benefits, the patient needs to meet the following criteria: Participate in a comprehensive lifestyle intervention (CLI) that includes diet, exercise, and behavioral changes
We are a family-owned weight loss clinic offering healthy lifestyle changes to help you lose weight and keep it off